Aurobindo Pharma approves ₹800 cr share buyback plan
after close1 source ↓written by the desknot a recommendation
- buyback plan
- ₹800 cr
- equity shares
- 54.23 lakh
- each
- ₹1,475
- over the previous
- 10% premium
- closing price
- ₹1,335.95
Aurobindo Pharma’s Board has approved a ₹800 cr buyback plan for 54.23 lakh equity shares at ₹1,475 each, a 10% premium over the previous closing price of ₹1,335.95. The record date for eligibility is set for 17 Apr 2026. This marks the company's second buyback in under two years, potentially enhancing shareholder value.
Not investment advice. For informational purposes only.